Recently, we have identified two astrocytic subpopulations in the cortex of GFAP-EGFP mice, in which the astrocytes are visualized by the enhanced green–fluorescent protein (EGFP) under the control of the human glial fibrillary acidic protein (GFAP) promotor. These astrocytic subpopulations, termed high response- (HR-) and low response- (LR-) astrocytes, differed in the extent of their swelling during oxygen-glucose deprivation (OGD). In the present study we focused on identifying the ion channels or transporters that might underlie the different capabilities of these two astrocytic subpopulations to regulate their volume during OGD. Using three-dimensional confocal morphometry, which enables quantification of the total astrocytic volume, the effects of selected inhibitors of K+ and Cl？ channels/transporters or glutamate transporters on astrocyte volume changes were determined during 20 minute-OGD in situ. The inhibition of volume regulated anion channels (VRACs) and two-pore domain potassium channels (K2P) highlighted their distinct contributions to volume regulation in HR-/LR-astrocytes. While the inhibition of VRACs or K2P channels revealed their contribution to the swelling of HR-astrocytes, in LR-astrocytes they were both involved in anion/K+ effluxes. Additionally, the inhibition of Na+-K+-Cl？ co-transporters in HR-astrocytes led to a reduction of cell swelling, but it had no effect on LR-astrocyte volume. Moreover, employing real-time single-cell quantitative polymerase chain reaction (PCR), we characterized the expression profiles of EGFP-positive astrocytes with a focus on those ion channels and transporters participating in astrocyte swelling and volume regulation. The PCR data revealed the existence of two astrocytic subpopulations markedly differing in their gene expression levels for inwardly rectifying K+ channels (Kir4.1), K2P channels (TREK-1 and TWIK-1) and Cl？ channels (ClC2). Thus, we propose that the diverse volume changes displayed by cortical astrocytes during OGD mainly result from their distinct expression patterns of ClC2 and K2P channels.
References
[1]
Mongin AA (2007) Disruption of ionic and cell volume homeostasis in cerebral ischemia: The perfect storm. Pathophysiology 14: 183–193.
[2]
Phillis JW, Ren J, O'Regan MH (2000) Transporter reversal as a mechanism of glutamate release from the ischemic rat cerebral cortex: studies with DL-threo-beta-benzyloxyaspartate. Brain Res 880: 224.
[3]
Kahle KT, Simard JM, Staley KJ, Nahed BV, Jones PS, et al. (2009) Molecular mechanisms of ischemic cerebral edema: role of electroneutral ion transport. Physiology (Bethesda) 24: 257–265.
[4]
Ringel F, Plesnila N (2008) Expression and functional role of potassium-chloride cotransporters (KCC) in astrocytes and C6 glioma cells. Neurosci Lett 442: 219–223.
[5]
Ochoa-de la Paz LD, Lezama R, Toscano B, Pasantes-Morales H (2005) Mechanisms of chloride influx during KCl-induced swelling in the chicken retina. Pflugers Arch 449: 526–536.
[6]
Kimelberg HK (2005) Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 50: 389–397.
[7]
Butt AM, Kalsi A (2006) Inwardly rectifying potassium channels (Kir) in central nervous system glia: a special role for Kir4.1 in glial functions. J Cell Mol Med 10: 33–44.
[8]
Nagelhus EA, Mathiisen TM, Ottersen OP (2004) Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with KIR4.1. Neuroscience 129: 905–913.
[9]
Pasler D, Gabriel S, Heinemann U (2007) Two-pore-domain potassium channels contribute to neuronal potassium release and glial potassium buffering in the rat hippocampus. Brain Res 1173: 14–26.
[10]
Skatchkov SN, Eaton MJ, Shuba YM, Kucheryavykh YV, Derst C, et al. (2006) Tandem-pore domain potassium channels are functionally expressed in retinal (Muller) glial cells. Glia 53: 266–276.
[11]
Buckler KJ, Honore E (2005) The lipid-activated two-pore domain K+ channel TREK-1 is resistant to hypoxia: implication for ischaemic neuroprotection. J Physiol 562: 213–222.
[12]
Kucheryavykh LY, Kucheryavykh YV, Inyushin M, Shuba YM, Sanabria P, et al. (2009) Ischemia Increases TREK-2 Channel Expression in Astrocytes: Relevance to Glutamate Clearance. Open Neurosci J 3: 40–47.
[13]
Okada Y, Sato K, Numata T (2009) Pathophysiology and puzzles of the volume-sensitive outwardly rectifying anion channel. J Physiol 587: 2141–2149.
[14]
Kimelberg HK, Jin Y, Charniga C, Feustel PJ (2003) Neuroprotective activity of tamoxifen in permanent focal ischemia. J Neurosurg 99: 138–142.
[15]
Zhang Y, Zhang H, Feustel PJ, Kimelberg HK (2008) DCPIB, a specific inhibitor of volume regulated anion channels (VRACs), reduces infarct size in MCAo and the release of glutamate in the ischemic cortical penumbra. Exp Neurol 210: 514–520.
[16]
Inoue H, Okada Y (2007) Roles of volume-sensitive chloride channel in excitotoxic neuronal injury. J Neurosci 27: 1445–1455.
[17]
Chvatal A, Anderova M, Hock M, Prajerova I, Neprasova H, et al. (2007) Three-dimensional confocal morphometry reveals structural changes in astrocyte morphology in situ. J Neurosci Res 85: 260–271.
[18]
Chvatal A, Anderova M, Kirchhoff F (2007) Three-dimensional confocal morphometry - a new approach for studying dynamic changes in cell morphology in brain slices. J Anat 210: 671–683.
[19]
Nolte C, Matyash M, Pivneva T, Schipke CG, Ohlemeyer C, et al. (2001) GFAP promoter-controlled EGFP-expressing transgenic mice: a tool to visualize astrocytes and astrogliosis in living brain tissue. Glia 33: 72–86.
[20]
Benesova J, Hock M, Butenko O, Prajerova I, Anderova M, et al. (2009) Quantification of astrocyte volume changes during ischemia in situ reveals two populations of astrocytes in the cortex of GFAP/EGFP mice. J Neurosci Res 87: 96–111.
[21]
Stahlberg A, Andersson D, Aurelius J, Faiz M, Pekna M, et al. (2011) Defining cell populations with single-cell gene expression profiling: correlations and identification of astrocyte subpopulations. Nucleic Acids Res 39: e24.
[22]
Bergkvist A, Rusnakova V, Sindelka R, Garda JM, Sjogreen B, et al. (2010) Gene expression profiling–Clusters of possibilities. Methods 50: 323–335.
[23]
Matyash V, Kettenmann H (2010) Heterogeneity in astrocyte morphology and physiology. Brain Res Rev 63: 2–10.
[24]
Abdullaev IF, Rudkouskaya A, Schools GP, Kimelberg HK, Mongin AA (2006) Pharmacological comparison of swelling-activated excitatory amino acid release and Cl- currents in cultured rat astrocytes. J Physiol 572: 677–689.
[25]
Pivonkova H, Benesova J, Butenko O, Chvatal A, Anderova M (2010) Impact of global cerebral ischemia on K+ channel expression and membrane properties of glial cells in the rat hippocampus. Neurochem Int 57: 783–794.
[26]
Seifert G, Huttmann K, Binder DK, Hartmann C, Wyczynski A, et al. (2009) Analysis of astroglial K+ channel expression in the developing hippocampus reveals a predominant role of the Kir4.1 subunit. J Neurosci 29: 7474–7488.
[27]
Zhou M, Xu G, Xie M, Zhang X, Schools GP, et al. (2009) TWIK-1 and TREK-1 are potassium channels contributing significantly to astrocyte passive conductance in rat hippocampal slices. J Neurosci 29: 8551–8564.
[28]
Liu M, Dziennis S, Hurn PD, Alkayed NJ (2009) Mechanisms of gender-linked ischemic brain injury. Restor Neurol Neurosci 27: 163–179.
[29]
Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, et al. (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci 28: 264–278.
[30]
Stahlberg A, Elbing K, Andrade-Garda JM, Sjogreen B, Forootan A, et al. (2008) Multiway real-time PCR gene expression profiling in yeast Saccharomyces cerevisiae reveals altered transcriptional response of ADH-genes to glucose stimuli. BMC Genomics 9: 170.
[31]
Enyedi P, Czirjak G (2010) Molecular background of leak K+ currents: two-pore domain potassium channels. Physiol Rev 90: 559–605.
[32]
Dibaj P, Kaiser M, Hirrlinger J, Kirchhoff F, Neusch C (2007) Kir4.1 channels regulate swelling of astroglial processes in experimental spinal cord edema. J Neurochem.
[33]
Hirrlinger PG, Wurm A, Hirrlinger J, Bringmann A, Reichenbach A (2008) Osmotic swelling characteristics of glial cells in the murine hippocampus, cerebellum, and retina in situ. J Neurochem 105: 1405–1417.
[34]
Obara-Michlewska M, Jiang H, Aschner M, Albrecht J (2010) Gain of function of Kir4.1 channel increases cell resistance to changes of potassium fluxes and cell volume evoked by ammonia and hypoosmotic stress. Pharmacol Rep 62: 1237–1242.
[35]
Obara-Michlewska M, Pannicke T, Karl A, Bringmann A, Reichenbach A, et al. (2011) Down-regulation of Kir4.1 in the cerebral cortex of rats with liver failure and in cultured astrocytes treated with glutamine: Implications for astrocytic dysfunction in hepatic encephalopathy. J Neurosci Res 89: 2018–2027.
[36]
Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, et al. (2010) Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev 90: 291–366.
[37]
Ernest NJ, Weaver AK, Van Duyn LB, Sontheimer HW (2005) Relative contribution of chloride channels and transporters to regulatory volume decrease in human glioma cells. Am J Physiol Cell Physiol 288: C1451–1460.
[38]
Parkerson KA, Sontheimer H (2003) Contribution of chloride channels to volume regulation of cortical astrocytes. Am J Physiol Cell Physiol 284: C1460–1467.
[39]
Nilius B, Droogmans G (2003) Amazing chloride channels: an overview. Acta Physiol Scand 177: 119–147.
[40]
Price DL, Ludwig JW, Mi H, Schwarz TL, Ellisman MH (2002) Distribution of rSlo Ca2+-activated K+ channels in rat astrocyte perivascular endfeet. Brain Res 956: 183–193.
[41]
Amiry-Moghaddam M, Frydenlund DS, Ottersen OP (2004) Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport. Neuroscience 129: 999–1010.
[42]
Hibino H, Higashi-Shingai K, Fujita A, Iwai K, Ishii M, et al. (2004) Expression of an inwardly rectifying K+ channel, Kir5.1, in specific types of fibrocytes in the cochlear lateral wall suggests its functional importance in the establishment of endocochlear potential. Eur J Neurosci 19: 76–84.
[43]
Benfenati V, Caprini M, Dovizio M, Mylonakou MN, Ferroni S, et al. (2011) An aquaporin-4/transient receptor potential vanilloid 4 (AQP4/TRPV4) complex is essential for cell-volume control in astrocytes. Proc Natl Acad Sci U S A 108: 2563–2568.
[44]
Benfenati V, Amiry-Moghaddam M, Caprini M, Mylonakou MN, Rapisarda C, et al. (2007) Expression and functional characterization of transient receptor potential vanilloid-related channel 4 (TRPV4) in rat cortical astrocytes. Neuroscience 148: 876–892.
[45]
Beck J, Lenart B, Kintner DB, Sun D (2003) Na-K-Cl cotransporter contributes to glutamate-mediated excitotoxicity. J Neurosci 23: 5061–5068.
[46]
Chen H, Luo J, Kintner DB, Shull GE, Sun D (2005) Na(+)-dependent chloride transporter (NKCC1)-null mice exhibit less gray and white matter damage after focal cerebral ischemia. J Cereb Blood Flow Metab 25: 54–66.
[47]
Su G, Kintner DB, Flagella M, Shull GE, Sun D (2002) Astrocytes from Na(+)-K(+)-Cl(？) cotransporter-null mice exhibit absence of swelling and decrease in EAA release. Am J Physiol Cell Physiol 282: C1147–1160.
[48]
Su G, Kintner DB, Sun D (2002) Contribution of Na(+)-K(+)-Cl(？) cotransporter to high-[K(+)](o)- induced swelling and EAA release in astrocytes. Am J Physiol Cell Physiol 282: C1136–1146.
[49]
Yan Y, Dempsey RJ, Flemmer A, Forbush B, Sun D (2003) Inhibition of Na(+)-K(+)-Cl(？) cotransporter during focal cerebral ischemia decreases edema and neuronal damage. Brain Res 961: 22–31.
[50]
Yan Y, Dempsey RJ, Sun D (2001) Expression of Na(+)-K(+)-Cl(？) cotransporter in rat brain during development and its localization in mature astrocytes. Brain Res 911: 43–55.
[51]
Koyama Y, Baba A, Iwata H (1991) L-glutamate-induced swelling of cultured astrocytes is dependent on extracellular Ca2+. Neurosci Lett 122: 210–212.
[52]
Schneider GH, Baethmann A, Kempski O (1992) Mechanisms of glial swelling induced by glutamate. Can J Physiol Pharmacol 70: SupplS334–343.
[53]
Shimamoto K, Lebrun B, Yasuda-Kamatani Y, Sakaitani M, Shigeri Y, et al. (1998) DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol Pharmacol 53: 195–201.
